Some of the names on the move ahead of the open. » Read More
As Obama's disapproval rate goes up, so will the companies that he targets.
Plus, get calls on health care and much more.
Not having a public option in the Obama healthcare reform bill is good for the the larger managed care group, says health care analyst Thomas Carroll of Stifel Nicoluas.
Markets are likely to end the year higher and investors need some strong, blue-chip stocks in their portfolios, to counteract the volatility shown by cyclical shares, Bob Doll, global chief investment officer of equities at BlackRock, told CNBC Tuesday.
Amid the sell off, what level should you be closely watching in the S&P as a level of support?
Warren Buffett's Berkshire Hathaway was doing more selling than buying of stocks during the second quarter, but there is one new holding: New Jersey-based medical technology company Becton Dickinson. Berkshire also added to its stake in Johnson & Johnson, although the holdings are still well below where they were before Buffett sold over 33 million shares last fall.
Plus, get calls on health care, real estate, IPOs and more.
For the insurance industry, long an opponent of health care reform, it was a striking change: with a new administration coming to Washington, insurers agreed to abandon some of their most controversial practices, like denying coverage to applicants with pre-existing medical conditions.
A hot July for stocks has set the stage for a rally that should run right into August.
Wall Street's bull just won't give up, even in the face of crumbling support from oil and the dollar.
Stocks declined Wednesday as weak demand for today's Treasury auction and a sharp drop in oil prices dragged on the market. A disappointing durable-goods report didn't help either.
Stocks declined Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.
Futures tumbled Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.
Options traders were snapping up calls in UnitedHealth Group yesterday amid new hopes that health care policy changes might be less harmful to the industry than originally thought.
The bulls are still in charge, for now.
Stocks ended slightly lower Tuesday, though the Nasdaq eked out a gain. And Citigroup shares soared.
The Mad Money host tells us which stocks work as a result. Plus, get calls on the banks, housing and more.
So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate. This week there are over 20 more healthcare companies reporting. Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.
Opposition to the Obama administration's health care plan had a new voice Monday, as the U.S. Chamber of Commerce launched a critical ad campaign suggesting alternatives. But John Sullivan of Leerink Swann says this is a great time to buy health stocks.
While the public is continuing to obsess over the generally better than expected earnings and the two-week, 100 point rise in the S&P 500 (11 percent), stock traders are nervously eyeing the $200 billion in new Treasury debt that is coming this week.